Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation.

Lee SR, Choi EK, Han KD, Jung JH, Oh S, Lip GYH. Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation. Sci Rep. 2019 04 30; 9(1):6690.

View in: PubMed

subject areas

Administration, Oral
Aged
Aged, 80 and over
Atrial Fibrillation
Cause of Death
Disease Susceptibility
Drug Administration Schedule
Female
Flow Cytometry
Follow-Up Studies
Hemorrhage
Humans
Incidence
Infant
Male
Middle Aged
Population Surveillance
Pyridines
Thiazoles

authors with profiles

Kyung-An Han

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support